Stay updated on Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial
Sign up to get notified when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.

Latest updates to the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page
- ChecktodayChange DetectedDifference0.2%
- Check8 days agoChange DetectedThe page has been updated to include new drug information, specifically the addition of Tucatinib and Vinorelbine, while significant details about the ZW25 study have been removed, including its phases and eligibility criteria.SummaryDifference45%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoChange DetectedThe page has been updated to include information on Stomach Cancer while removing references to Ovarian Cancer. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.SummaryDifference0.2%
- Check30 days agoChange DetectedDifference0.2%
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.